LETPOINT 2.5 contains Letrozole 2.5 mg, an aromatase inhibitor used in ovulation induction for selected infertility cases and in other hormone-dependent indications as prescribed. A specialized PCD Gynae portfolio product.
Ovulation induction in selected women with infertility and for certain hormone-sensitive breast cancers.
No, fertility use requires medical supervision.
Use strictly according to the fertility specialist’s schedule. Ovulation and treatment response may require monitoring. Do not self-medicate or use during pregnancy.
Hot flushes, headache, nausea, fatigue, dizziness, joint or muscle pain may occur.
LETPOINT 2.5: Letrozole inhibits aromatase, reducing estrogen production and thereby stimulating the hormonal environment required for ovulation in appropriately selected women.
